<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Process" Owner="NLM">        <PMID Version="1">30049201</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>05</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">2476-762X</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>19</Volume>                    <Issue>7</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>07</Month>                        <Day>27</Day>                    </PubDate>                </JournalIssue>                <Title>Asian Pacific journal of cancer prevention : APJCP</Title>                <ISOAbbreviation>Asian Pac. J. Cancer Prev.</ISOAbbreviation>            </Journal>            <ArticleTitle>Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer</ArticleTitle>            <Pagination>                <MedlinePgn>1887-1893</MedlinePgn>            </Pagination>            <Abstract>                <AbstractText>Objective: This study investigated the DNA promoter methylation profiles of BRCA1, RASSF1A and GSTP1 genes,both individually and in an integrative manner in order to clarify their correlation with clinicopathological parameters ofbreast cancer from Vietnamese patients, and establish new potential integrative methylation biomarkers for breast cancerdetection. Material and methods: The methylation frequencies of BRCA1, RASSF1A and GSTP1 were analyzed bymethylation specific polymerase chain reaction (MSP) in 70 specimens of breast carcinomas and 79 pairs of tumor andmatched adjacent normal tissues from breast cancer patients. Results: All the three analyzed genes showed a concordanceconcerning their promoter methylation in tumor and adjacent normal tissue. The methylation of BRCA1, RASSF1Aand GSTP1 was found in 58.23 %, 74.68 % and 59.49 % of tumor tissues and 51.90 %, 63.29 % and 35.44 % ofcorresponding adjacent tissues, respectively. When each gene was assessed individually, only the methylation ofGSTP1 was significantly associated with tumor tissues (p=0.003). However, the methylation frequency of at least one ofthe three genes and the methylation frequency of all the three genes both showed significant association with tumor(p=0.008 and p=0.04, respectively). The methylation of BRCA1 was found to be significantly associated with tumorgrade (p=0.01). Conclusion: This study emphasized that the panel of the three genes BRCA1, RASSF1A and GSTP1can be further developed as potential biomarkers in diagnosis and classification of breast cancer in Vietnamese women.</AbstractText>                <CopyrightInformation>Creative Commons Attribution License</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y" EqualContrib="Y">                    <LastName>Vu</LastName>                    <ForeName>Trang Lan</ForeName>                    <Initials>TL</Initials>                    <AffiliationInfo>                        <Affiliation>Sorbonne University, UPMC Univ. Paris 06, École Normale Supérieure, PSL Research University, CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), Paris, France. Email: vothithuonglan@hus.edu.vn.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y" EqualContrib="Y">                    <LastName>Nguyen</LastName>                    <ForeName>Trang Thu</ForeName>                    <Initials>TT</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Doan</LastName>                    <ForeName>Van Thi Hong</ForeName>                    <Initials>VTH</Initials>                </Author>                <Author ValidYN="Y">                    <LastName>Vo</LastName>                    <ForeName>Lan Thi Thuong</ForeName>                    <Initials>LTT</Initials>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>27</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>Thailand</Country>            <MedlineTA>Asian Pac J Cancer Prev</MedlineTA>            <NlmUniqueID>101130625</NlmUniqueID>            <ISSNLinking>1513-7368</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2016 Jan 29;7:10478</RefSource>                <PMID Version="1">26823093</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2015 Nov 19;15:920</RefSource>                <PMID Version="1">26585467</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epigenetics. 2015 Jul 25;7:75</RefSource>                <PMID Version="1">26213588</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Life Sci. 2010 Jul 17;87(3-4):83-91</RefSource>                <PMID Version="1">20470789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2003 Jan 9;22(1):147-50</RefSource>                <PMID Version="1">12527916</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7414-7419</RefSource>                <PMID Version="1">28652331</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821-6</RefSource>                <PMID Version="1">8790415</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2017 Nov 15;33(22):3619-3626</RefSource>                <PMID Version="1">28961949</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Turk J Med Sci. 2016 Jan 05;46(1):228-35</RefSource>                <PMID Version="1">27511358</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2016 Jul 27;11(7):e0160174</RefSource>                <PMID Version="1">27463681</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dis Markers. 2007;23(1-2):73-87</RefSource>                <PMID Version="1">17325427</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Fam Cancer. 2009;8(4):339-46</RefSource>                <PMID Version="1">19340607</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(5):e36780</RefSource>                <PMID Version="1">22615811</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Adv Exp Med Biol. 2016;882:169-89</RefSource>                <PMID Version="1">26987535</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Chem. 2009 Aug;55(8):1471-83</RefSource>                <PMID Version="1">19520761</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Clin Oncol. 2015 Nov;3(6):1353-1360</RefSource>                <PMID Version="1">26807247</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Cancer. 2006 Feb;6(2):107-16</RefSource>                <PMID Version="1">16491070</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2015 May 19;15:417</RefSource>                <PMID Version="1">25986046</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Biol Med. 2015 Sep;12(3):238-45</RefSource>                <PMID Version="1">26487968</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2006 Nov 15;12(22):6626-36</RefSource>                <PMID Version="1">17121881</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2014;15(22):9607-10</RefSource>                <PMID Version="1">25520075</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Genet. 2011 Jul;80(1):89-92</RefSource>                <PMID Version="1">20950396</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Death Differ. 2010 Sep;17(9):1373-80</RefSource>                <PMID Version="1">20596078</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Med. 2016 Dec;5(12):3475-3488</RefSource>                <PMID Version="1">27774765</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2005 May 1;65(9):3497-508</RefSource>                <PMID Version="1">15867337</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anticancer Res. 2010 Jul;30(7):2489-96</RefSource>                <PMID Version="1">20682973</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Breast Cancer. 2016;2016:9545241</RefSource>                <PMID Version="1">27413552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2005 Jan 1;11(1):166-72</RefSource>                <PMID Version="1">15671542</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2001 Apr 15;61(8):3225-9</RefSource>                <PMID Version="1">11309270</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Tumour Biol. 2017 Apr;39(4):1010428317697563</RefSource>                <PMID Version="1">28443466</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Breast Cancer. 2017 Mar;20(1):12-19</RefSource>                <PMID Version="1">28382090</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cancer Ther Res. 2014 Mar 19;3(2):1-11</RefSource>                <PMID Version="1">25177489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Biol. 2014;15(8):435</RefSource>                <PMID Version="1">25146004</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Cancer. 2010 Jan 15;126(2):474-82</RefSource>                <PMID Version="1">19618401</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Lab Med. 2013 Nov;33(6):431-40</RefSource>                <PMID Version="1">24205493</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Transl Gastroenterol. 2017 Jan 19;8(1):e216</RefSource>                <PMID Version="1">28102859</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2006 Mar 06;34(5):1416-26</RefSource>                <PMID Version="1">16522651</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Cancer. 2010 Mar 12;10:97</RefSource>                <PMID Version="1">20226036</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Med Rep. 2014 May;9(5):1844-50</RefSource>                <PMID Version="1">24573411</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Brief Funct Genomics. 2018 Jan 1;17(1):49-63</RefSource>                <PMID Version="1">28968850</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2014 Oct;105(10):1369-76</RefSource>                <PMID Version="1">25155055</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Exp Clin Cancer Res. 2013 Nov 19;32:94</RefSource>                <PMID Version="1">24252461</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Rev Clin Oncol. 2015 Jul;12(7):381-94</RefSource>                <PMID Version="1">25895611</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2014;15(24):10585-9</RefSource>                <PMID Version="1">25605143</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2014 Oct 21;16(5):423</RefSource>                <PMID Version="1">25331261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2015 Dec 08;5:17869</RefSource>                <PMID Version="1">26643130</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epigenetics. 2016 Nov 14;8:115</RefSource>                <PMID Version="1">27895805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asian Pac J Cancer Prev. 2013;14(12):7713-8</RefSource>                <PMID Version="1">24460357</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2015 Jul 28;113(3):372-81</RefSource>                <PMID Version="1">26158424</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Sci Rep. 2016 Apr 20;6:24706</RefSource>                <PMID Version="1">27094684</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30</RefSource>                <PMID Version="1">26742998</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epigenetics. 2016 Oct 19;8:109</RefSource>                <PMID Version="1">27777637</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Medicine (Baltimore). 2017 Jul;96(28):e7476</RefSource>                <PMID Version="1">28700487</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Virchows Arch. 2007 Jun;450(6):637-42</RefSource>                <PMID Version="1">17479284</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2015 Jan;43(Database issue):D856-61</RefSource>                <PMID Version="1">25398901</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dis Markers. 2017;2017:3726595</RefSource>                <PMID Version="1">29038612</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Inform. 2016 Sep 07;15(Supple 4):1-9</RefSource>                <PMID Version="1">27688708</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Sci. 2009 Sep;100(9):1663-7</RefSource>                <PMID Version="1">19522853</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Pathology. 2005 Apr;37(2):125-30</RefSource>                <PMID Version="1">16028839</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">Breast cancer 1 (BRCA1)</Keyword>            <Keyword MajorTopicYN="Y">RAS-association domain family member 1 (RASSF1A)</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>7</Month>                <Day>28</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30049201</ArticleId>            <ArticleId IdType="doi">10.22034/APJCP.2018.19.7.1887</ArticleId>            <ArticleId IdType="pmc">PMC6165660</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>